{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:36:09Z","timestamp":1791948969446,"version":"4.3.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/bjd.14756","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T10:12:46Z","timestamp":1464084766000},"page":"1166-1174","source":"Crossref","is-referenced-by-count":48,"title":["Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"175","author":[{"given":"F.","family":"Petrelli","sequence":"first","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Borgonovo","sequence":"additional","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cabiddu","sequence":"additional","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Coinu","sequence":"additional","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ghilardi","sequence":"additional","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lonati","sequence":"additional","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barni","sequence":"additional","affiliation":[{"name":"Oncology Unit; Oncology Department; ASST Bergamo Ovest; Piazzale Ospedale 1 24047 Treviglio (BG) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"10.1111\/bjd.14756-BIB0001|bjd14756-cit-0001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000229751","article-title":"Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147","volume":"77","author":"Jatoi","year":"2009","journal-title":"Oncology"},{"key":"10.1111\/bjd.14756-BIB0002|bjd14756-cit-0002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2230.2011.04117.x","article-title":"Higher severity grade of erlotinib-induced rash is associated with lower skin phototype","volume":"36","author":"Luu","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.14756-BIB0003|bjd14756-cit-0003","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11523-013-0257-x","article-title":"The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials","volume":"8","author":"Petrelli","year":"2013","journal-title":"Target Oncol"},{"key":"10.1111\/bjd.14756-BIB0004|bjd14756-cit-0004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lungcan.2012.06.009","article-title":"Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: a literature-based meta-analysis of 24 trials","volume":"78","author":"Petrelli","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1111\/bjd.14756-BIB0005|bjd14756-cit-0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/bjd.14756-BIB0006|bjd14756-cit-0006","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.critrevonc.2015.06.001","article-title":"Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: literature review and consensus","volume":"96","author":"Russi","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1111\/bjd.14756-BIB0007|bjd14756-cit-0007","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1634\/theoncologist.2010-0298","article-title":"Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy","volume":"16","author":"Pinto","year":"2011","journal-title":"Oncologist"},{"key":"10.1111\/bjd.14756-BIB0008|bjd14756-cit-0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/annonc\/mdm400","article-title":"Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck","volume":"19","author":"Bernier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.14756-BIB0009|bjd14756-cit-0009","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00520-011-1197-6","article-title":"Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities","volume":"19","author":"Lacouture","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1111\/bjd.14756-BIB0010|bjd14756-cit-0010","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1200\/JCO.2008.21.7828","article-title":"Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer","volume":"28","author":"Lacouture","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14756-BIB0011|bjd14756-cit-0011","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1634\/theoncologist.2011-0365","article-title":"Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review","volume":"17","author":"Bachet","year":"2012","journal-title":"Oncologist"},{"key":"10.1111\/bjd.14756-BIB0012|bjd14756-cit-0012","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/bjd.14756-BIB0013|bjd14756-cit-0013","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions http:\/\/handbook.cochrane.org\/"},{"key":"10.1111\/bjd.14756-BIB0014|bjd14756-cit-0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1111\/bjd.14756-BIB0015|bjd14756-cit-0015","first-page":"6175","article-title":"Prophylactic effect of oral minocycline in combination with topical steroid and skin care against panitumumab-induced acneiform rash in metastatic colorectal cancer patients","volume":"35","author":"Yamada","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1111\/bjd.14756-BIB0016|bjd14756-cit-0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/cncr.23621","article-title":"Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB)","volume":"113","author":"Jatoi","year":"2008","journal-title":"Cancer"},{"key":"10.1111\/bjd.14756-BIB0017|bjd14756-cit-0017","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2007.12.6987","article-title":"Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption","volume":"25","author":"Scope","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14756-BIB0018|bjd14756-cit-0018","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40257-015-0116-x","article-title":"Efficacy of prophylactic minocycline treatment for skin toxicities induced by erlotinib plus gemcitabine in patients with advanced pancreatic cancer: a retrospective study","volume":"16","author":"Shinohara","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.14756-BIB0019|bjd14756-cit-0019","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00432-013-1483-4","article-title":"Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective","volume":"139","author":"Wehler","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/bjd.14756-BIB0020|bjd14756-cit-0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/fon.14.251","article-title":"Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP","volume":"11","author":"Kobayashi","year":"2015","journal-title":"Future Oncol"},{"key":"10.1111\/bjd.14756-BIB0021|bjd14756-cit-0021","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.lungcan.2015.03.019","article-title":"Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients","volume":"88","author":"Arrieta","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1111\/bjd.14756-BIB0022|bjd14756-cit-0022","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00520-010-0988-5","article-title":"Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)","volume":"19","author":"Jatoi","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1111\/bjd.14756-BIB0023|bjd14756-cit-0023","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1200\/JCO.2015.62.3918","article-title":"Pan Canadian Rash Trial: a randomized phase III trial evaluating the impact of a prophylactic skin treatment regimen on epidermal growth factor receptor-tyrosine kinase inhibitor-induced skin toxicities in patients with metastatic lung cancer","volume":"34","author":"Melosky","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14756-BIB0024|bjd14756-cit-0024","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaad.2016.01.019","article-title":"Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: a randomized, open-label trial","volume":"74","author":"Deplanque","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"15 Suppl. 1","key":"10.1111\/bjd.14756-BIB0025|bjd14756-cit-0025","first-page":"e19049","article-title":"Prophylactic doxycycline (doxy) lessens rash from dacomitinib (D) an EGFR inhibitor with no rash or diarrhea improvement from corticosteroids or probiotics","volume":"33","author":"Lacouture","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2 Suppl. 1","key":"10.1111\/bjd.14756-BIB0026|bjd14756-cit-0026","first-page":"S110","article-title":"Supportive care intervention trials as a way to improve toxicity management during concurrent chemoradiation for locally advanced NSCLC","volume":"19","author":"Heuvel","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1111\/bjd.14756-BIB0027|bjd14756-cit-0027","doi-asserted-by":"crossref","first-page":"199ra111","DOI":"10.1126\/scitranslmed.3005886","article-title":"Epidermal EGFR controls cutaneous host defense and prevents inflammation","volume":"5","author":"Lichtenberger","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1111\/bjd.14756-BIB0028|bjd14756-cit-0028","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","article-title":"Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation","volume":"163","author":"Mascia","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.14756-BIB0029|bjd14756-cit-0029","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2133.2012.10845.x","article-title":"Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature","volume":"166","author":"Lebrun-Vignes","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14756-BIB0030|bjd14756-cit-0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cllc.2014.04.006","article-title":"Management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysis","volume":"15","author":"Passaro","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1111\/bjd.14756-BIB0031|bjd14756-cit-0031","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00520-015-2846-y","article-title":"Prophylactic versus reactive treatment of acneiform skin rashes from epidermal growth factor receptor inhibitors in metastatic colorectal cancer","volume":"24","author":"Dascalu","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1111\/bjd.14756-BIB0032|bjd14756-cit-0032","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1468-3083.2011.04324.x","article-title":"Phytomenadione pre-treatment in EGFR inhibitor-induced folliculitis","volume":"27","author":"Tomkov\u00e1","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14756-BIB0033|bjd14756-cit-0033","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clcc.2013.10.001","article-title":"Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer","volume":"13","author":"Pinta","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"10.1111\/bjd.14756-BIB0034|bjd14756-cit-0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1684\/ejd.2012.1899","article-title":"Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer","volume":"23","author":"Jo","year":"2013","journal-title":"Eur J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14756","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14756","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14756\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:21:26Z","timestamp":1676384486000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/6\/1166\/6698425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14756","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9,30]]}}}